anthea
anantharajah
rohan
essex
matthew
cook
depart
immunolog
canberra
hospit
canberra
australia
depart
ophthalmolog
canberra
hospit
canberra
australia
australian
nation
univers
canberra
australia
local
system
sarcoid
reaction
rare
emerg
phenomena
follow
tattoo
variou
aetiolog
mechan
postul
includ
system
hypersensit
tattoo
pigment
koebner
phenomenon
predispos
host
describ
one
case
small
seri
manifest
distant
inflamm
concomit
tattoo
involv
find
may
provid
new
insight
understand
conundrum
sarcoid
pathogenesi
year
old
profession
tattoo
artist
present
late
week
histori
blur
vision
bilater
ocular
pain
extens
tattoo
varieti
pigment
recent
obtain
new
black
tattoo
initi
heal
subsequ
becam
rais
inflam
examin
reveal
bilater
panuv
associ
disc
oedema
investig
reveal
evid
mycobacteri
infecti
caus
fluorescein
angiographi
demonstr
featur
vascul
howev
serum
angiotensin
convert
enzym
ace
elev
whole
bodi
gallium
scan
demonstr
increas
uptak
inguin
region
localis
lymph
node
radiolog
evid
pulmonari
involv
treat
initi
cyclopleg
topic
corticosteroid
howev
progress
eye
involv
develop
inflamm
previous
quiescent
tattoo
commenc
high
dose
corticosteroid
resolut
cutan
inflamm
partial
remiss
uveiti
ongo
flare
eye
involv
attempt
steroid
wean
despit
introduct
methotrex
although
isol
inflamm
uveal
tract
accompani
tattoo
granuloma
previous
describ
entiti
distinct
sarcoid
case
associ
elev
serum
ace
evid
nodal
involv
suggest
phenomena
may
lie
sarcoid
continuum
potenti
pathogen
mechan
discuss
jack
bourk
karen
wong
juliann
jackson
domin
mallon
bruce
bennett
lloyd
dorsogna
depart
clinic
immunolog
pathwest
fremantl
hospit
fremantl
western
australia
depart
molecular
genet
children
hospit
westmead
sydney
new
south
wale
depart
clinic
immunolog
pathwest
royal
perth
hospit
perth
western
australia
patholog
laboratori
medicin
univers
western
australia
perth
western
australia
background
autoinflammatori
diseas
rare
disord
characteris
inappropri
activ
inflammatori
pathway
includ
period
fever
syndrom
tumour
necrosi
factor
receptor
associ
period
fever
syndrom
trap
famili
mediterranean
fever
fmf
result
mutat
case
man
italian
descent
symptom
autoinflammatori
syndrom
sinc
age
episod
recurr
fever
arthralgia
seros
rais
inflammatori
marker
clinic
diagnosi
fmf
previous
made
without
genet
test
inflammatori
episod
often
extend
beyond
week
respons
colchicin
excel
respons
anakinra
therapi
observ
one
sister
experienc
almost
ident
symptom
although
episod
less
frequent
parent
sister
experi
symptom
period
fever
syndrom
three
children
unaffect
two
daughter
affect
sister
genet
test
fmf
perform
patient
mefv
gene
mutat
identifi
genet
test
trap
reveal
homozygos
novel
missens
mutat
gene
subsequ
test
famili
member
found
affect
individu
homozyg
mutat
heterozygot
famili
member
unaffect
parent
affect
sibl
could
test
howev
unaffect
must
also
heterozyg
mutat
famili
unawar
consanguin
howev
founder
effect
thought
possibl
case
conclus
trap
usual
inherit
autosom
domin
manner
howev
famili
inherit
appear
autosom
recess
gene
mutat
identifi
previous
describ
trap
demonstr
clinic
manifest
genet
mutat
trap
may
broader
previous
realis
furthermor
correct
genet
diagnosi
help
guid
effect
therapi
therebi
help
prevent
complic
amyloidosi
jie
shen
fok
kathryn
connel
william
b
smith
royal
adelaid
hospit
adelaid
australia
allergysa
adelaid
australia
background
mark
nut
semecarpu
anacardium
use
indian
religi
ceremoni
ayurved
medicin
like
cashew
nut
pistachio
mango
poison
ivi
belong
famili
anacardiacea
hand
report
case
contact
dermat
caus
mark
nut
report
case
anaphylaxi
mark
nut
ingest
best
knowledg
never
report
case
histori
hindu
templ
priest
ate
sweet
end
religi
ceremoni
within
minut
develop
eye
lip
swell
subsequ
develop
wheez
stridor
improv
adrenalin
salbutamol
nebulis
requir
anoth
dose
adrenalin
prednisolon
hospit
like
allergen
cofactor
ingredi
use
make
sweet
sought
skin
prick
test
neg
cow
milk
wheat
flour
peanut
cashew
pistachio
almond
coconut
gum
watercress
seed
posit
mark
nut
wheal
mm
advis
avoid
eat
mark
nut
futur
discussionconclus
plant
anacardiacea
caus
contact
allergi
plant
combin
howev
term
type
hypersensit
cashew
nut
allergi
common
mark
nut
allergi
describ
cross
reactiv
cashew
pistachio
mark
nut
might
expect
phylogenet
relat
case
mark
nut
present
uniqu
epitop
plan
carri
western
blot
identifi
allergen
protein
mark
nut
compar
known
cashew
pistachio
allergen
allergi
expect
occur
commonli
australia
recognit
use
sinc
like
seen
india
potenti
amongst
indian
expatri
lara
ford
tatjana
kilo
peter
hsu
melani
wong
diann
campbel
children
hospit
westmead
westmead
australia
univers
sydney
sydney
australia
term
boy
admit
histori
one
week
increas
neck
swell
initi
admiss
appropri
grown
low
grade
fever
tender
fluctuant
erythemat
right
cervic
mass
purul
ear
discharg
oral
thrush
hepatomegali
haemoglobin
gl
neutrophil
lymphocyt
protein
gl
haemoglobin
fell
gl
patient
transfus
antibiot
commenc
neck
lesion
discharg
spontan
grow
staphylococcu
aureu
abdomin
ultrasound
show
three
hyperecho
liver
lesion
immunoglobulin
elev
subset
normal
nbt
dhr
consist
chronic
granulomat
diseas
cgd
empir
antifung
therapi
oral
prednisolon
commenc
liver
lesion
gradual
resolv
howev
patient
develop
enter
initi
discharg
receiv
prophylact
bactrim
itraconazol
confirm
cgd
sequenc
cybb
gene
attempt
howev
amplif
use
standard
primer
fail
confirm
larg
delet
region
involv
cybb
xk
gene
xk
produc
kx
antigen
requir
biosynthesi
kell
antigen
normal
red
cell
morpholog
mutat
xk
associ
mcleod
phenotyp
result
haemolysi
possibl
neurolog
sequela
life
threaten
haemolysi
donor
signific
risk
sensitis
regist
mcleod
blood
donor
australia
present
screen
demonstr
absenc
kx
antigen
confirm
mcleod
phenotyp
presenc
antibodi
previou
transfus
presenc
antibodi
lack
avail
mcleod
blood
product
issu
complic
plan
bone
marrow
transplant
discuss
import
consid
mcleod
phenotyp
patient
cgd
issu
must
consid
bone
marrow
transplant
cgd
patient
mcleod
phenotyp
manag
strategi
issu
jovanka
king
adel
pajaro
renji
nelson
antonio
ferrant
tatjana
banov
pravin
hissaria
sa
patholog
adelaid
australia
royal
adelaid
hospit
adelaid
australia
robinson
research
institut
women
children
hospit
univers
adelaid
australia
flinder
univers
bedford
park
australia
present
case
old
man
experienc
reproduc
atyp
hypersensit
reaction
follow
ciprofloxacin
administr
patient
sustain
fractur
requir
surgic
manag
intern
fixat
complic
wound
dehisc
infect
treatment
includ
cours
intraven
tazocin
oral
ciprofloxacin
subsequ
develop
fever
generalis
rash
arthralgia
derang
liver
function
test
day
five
therapi
henc
antibiot
ceas
reaction
attribut
tazocin
ciprofloxacin
reintroduc
one
hour
follow
ciprofloxacin
administr
develop
fever
tongu
swell
pruriti
tachycardia
later
signific
hypotens
requir
intens
care
unit
admiss
serum
tryptas
normal
two
hour
onset
reaction
remain
persist
febril
five
day
symptom
attribut
sepsi
set
intercurr
infect
recov
oral
ciprofloxacin
result
rapid
onset
fever
rigor
generalis
erythema
pruriti
thirti
minut
follow
drug
administr
repeat
serum
tryptas
level
normal
recov
within
six
hour
support
therapi
administr
singl
dose
steroid
drug
hypersensit
reaction
may
classifi
accord
perceiv
mechan
drug
hypersensit
associ
specif
clinic
featur
onset
immedi
phase
follow
drug
administr
convers
featur
delay
drug
hypersensit
reaction
occur
sever
day
follow
exposur
differ
constel
clinic
symptomatolog
case
illustr
interest
situat
wherebi
typic
featur
delay
hypersensit
reaction
occur
acut
follow
administr
culprit
drug
notion
oxymoron
face
current
held
belief
regard
mechanist
typic
clinic
featur
drug
hypersensit
reaction
patient
clinic
present
result
subsequ
investig
discuss
possibl
mechan
reaction
present
moniqu
lee
louis
evan
john
quin
depart
clinic
immunolog
allergi
liverpool
hospit
sydney
australia
present
case
year
old
vietnames
man
admit
new
onset
fever
pleural
effus
pancytopenia
haemolyt
anaemia
preced
month
histori
cytopenia
anorexia
kg
weight
loss
alopecia
arthralgia
rash
well
episod
herp
zoster
autoimmun
serolog
initi
demonstr
homogen
ana
neg
ena
dsdna
level
iuml
low
complement
elev
rheumatoid
factor
high
ferritin
esr
crp
investig
underli
haematolog
malign
skin
bone
marrow
biopsi
admiss
serolog
evolut
demonstr
increas
dsdna
level
iuml
detect
ro
sm
ribonuclear
protein
antibodi
diagnosi
sle
made
treatment
initi
prednison
throughout
admiss
persist
pleural
effus
ascit
peripher
oedema
hypoalbuminaemia
gl
echocardiogram
demonstr
normal
left
ventricular
function
hr
urinari
protein
excret
g
bland
microscopi
normal
renal
function
renal
biopsi
unexpectedli
reveal
dens
deposit
diseas
result
complement
studi
present
dens
deposit
diseas
rare
condit
gener
describ
paediatr
popul
associ
dysregul
altern
complement
pathway
commonli
result
nephrit
factor
mutat
complement
regulatori
factor
h
contrast
defici
classic
complement
pathway
compon
associ
increas
suscept
sle
discuss
unusu
case
dens
deposit
diseas
adult
new
diagnosi
sle
relat
potenti
complement
abnorm
eton
lin
katherin
nichol
michael
sutherland
leonard
c
harrison
jo
douglass
depart
clinic
immunolog
allergi
royal
melbourn
hospit
melbourn
australia
univers
melbourn
melbourn
australia
depart
respiratori
sleep
medicin
austin
hospit
heidelberg
melbourn
australia
walter
eliza
hall
research
institut
melbourn
australia
background
acquir
angioedema
aae
character
symptomat
angioedema
esteras
inhibitor
defici
hereditari
angioedema
hae
type
ii
characteris
angioedema
earli
life
persist
low
function
report
case
angioedema
low
function
case
report
woman
without
famili
histori
angioedema
autoimmun
diseas
present
recurr
episod
angioedema
face
hand
abdomin
pain
first
pregnanc
condit
respons
antihistamin
serial
test
show
persist
low
function
normal
concentr
mgl
mgl
autoimmun
diseas
malign
screen
neg
diagnos
hae
type
ii
treat
concentr
major
attack
subsequ
deliv
healthi
infant
deliveri
symptom
subsid
remain
month
without
treatment
report
symptom
menstrual
cycl
repeat
test
month
show
normal
function
concentr
mgl
howev
second
pregnanc
second
trimest
symptomat
angioedema
recur
test
show
low
function
normal
concentr
mgl
reconsider
hae
type
ii
unlik
base
adult
onset
intermitt
low
function
diagnosi
revis
aae
conclus
report
unusu
case
intermitt
dysfunct
associ
recurr
angioedema
pregnanc
oestrogen
known
trigger
angioedema
type
iii
hae
thought
act
independ
aae
sometim
associ
lymphoprolif
disord
characteris
consumpt
presenc
autoantibodi
intermitt
dysfunct
might
explain
fluctuat
concentr
autoantibodi
karen
lindsay
traci
brigg
yanick
crow
carolin
meadow
ian
hay
sanjib
ghosh
depart
immunolog
auckland
citi
hospit
auckland
new
zealand
manchest
centr
genom
medicin
manchest
uk
depart
paediatr
whangarei
base
hospit
whangarei
new
zealand
genet
health
servic
auckland
nz
depart
rheumatolog
whangarei
base
hospit
whangarei
new
zealand
present
case
nz
famili
autosom
domin
genet
condit
featur
famili
chilblain
lupu
fcl
male
age
year
sister
age
year
daughter
age
year
vascul
onset
infanc
exacerb
cold
exposur
affect
acral
site
nose
cheek
ear
hand
feet
neurolog
deficit
organ
involv
refractori
immunosuppress
treatment
demonstr
highli
variabl
intrafamili
sever
rel
mild
lipoatrophi
face
lower
limb
hand
vascul
result
fix
pipj
contractur
recurr
lower
limb
vascul
winter
brother
sever
affect
person
famili
sever
facial
disfigur
affect
ear
nose
amput
four
limb
precipit
peripher
limb
ischaemia
deep
infect
similar
featur
mother
small
joint
involv
hand
feet
progress
despit
treatment
prednison
standard
dmard
cell
therapi
affect
individu
clinic
laboratori
featur
connect
tissu
diseas
normal
level
complement
factor
howev
demonstr
upregul
interferon
stimul
gene
consist
type
interferon
driven
diseas
mutat
identifi
current
known
syndromefcl
gene
phenotyp
famili
may
therefor
caus
presum
heterozyg
like
gain
function
mutat
novel
gene
case
present
discuss
difficult
manag
problem
pose
rang
special
paxton
loke
theresa
cole
sharon
choo
rachel
conyer
francois
mechinaud
mimi
lk
tang
depart
allergi
immunolog
royal
children
hospit
melbourn
australia
children
cancer
centr
royal
children
hospit
melbourn
australia
murdoch
children
research
institut
melbourn
australia
depart
paediatr
univers
melbourn
melbourn
australia
background
cur
treatment
sever
combin
immunodefici
scid
hematopoiet
stem
cell
transplant
hsct
recent
data
scid
due
vdj
recombin
defect
eg
suggest
poorer
outcom
follow
uncondit
vs
condit
hsct
mani
patient
requir
second
condit
hsct
case
highlight
critic
clinic
decis
make
respect
type
hsct
immedi
surviv
patient
paramount
case
histori
describ
month
old
boy
diagnos
scid
compound
heterozygot
mutat
omenn
syndrom
phenotyp
receiv
uncondit
match
sibl
hsct
month
age
present
respiratori
distress
eythroderma
peripher
oedema
failur
thrive
investig
demonstr
dissemin
adenoviru
infect
stool
blood
bal
pjp
pneumonia
bal
picornaviru
infect
npa
immun
function
investig
reveal
low
nk
phenotyp
undetect
naiv
cell
poor
lymphocyt
prolifer
phytohemagglutinin
pha
stimul
oligoclon
cell
elev
ige
level
develop
liver
dysfunct
secondari
adenoviru
infect
autoimmun
hepat
due
patient
worsen
adenoviru
hepat
despit
cidofovir
treatment
fact
match
sibl
donor
adenoviru
igg
posit
uncondit
hsct
perform
clearanc
adenoviru
achiev
immun
recoveri
slow
remain
clinic
well
conserv
approach
adopt
immun
reconstitut
monitor
regularli
nine
month
normal
cell
number
increas
number
cell
lymphocyt
prolifer
pha
normal
howev
b
cell
recoveri
poor
remain
immunoglobulin
replac
therapi
cell
donor
chimer
nine
month
present
antimicrobi
therapi
immunosuppress
remain
well
discuss
journey
begun
patient
continu
await
anticip
remark
recoveri
clair
nickol
alyson
kakakio
depart
allergi
immunolog
children
hospit
westmead
sydney
australia
present
case
young
boy
diagnos
sever
combin
immunodefici
scid
age
month
age
six
month
poor
feed
failur
thrive
recurr
respiratori
infect
oral
thrush
receiv
month
immunis
includ
measlesmumpsrubella
vaccin
admit
hospit
month
age
pneumonia
treat
intraven
iv
cefotaxim
examin
boy
weight
centil
febril
hypox
increas
work
breath
bilater
crackl
auscult
investig
reveal
normal
lymphocyt
count
absent
cell
absent
nk
cell
high
b
cell
igg
iga
absent
igm
low
gene
sequenc
reveal
mutat
common
gamma
chain
bronchoalveolar
lavag
posit
pneumocysti
coronaviru
polymeras
chain
reaction
pcr
aspergillu
fumigatu
cultur
commenc
oral
bactrim
iv
hydrocortison
iv
voriconazol
nasogastr
feed
signific
clinic
improv
weight
gain
human
leukocyt
antigen
hla
match
donor
bone
marrow
transplant
bmt
could
found
gene
therapi
unabl
pursu
lack
vector
australia
decis
made
proceed
matern
stem
cell
transplant
two
week
prior
bmt
patient
becam
unwel
enceph
caus
could
identifi
continu
deterior
despit
intraven
cefotaxim
ganciclovir
palliat
die
sever
day
condit
bmt
due
commenc
case
highlight
sever
pertin
point
includ
import
earli
diagnosi
scid
treatment
option
donor
bmt
avail
newborn
screen
scid
gene
therapi
scid
graft
manipul
haploident
bmt
discuss
stephani
richard
joann
smart
mimi
tang
sharon
choo
depart
allergi
immunolog
royal
children
hospit
melbourn
australia
immunolog
laboratori
laboratori
servic
royal
children
hospit
melbourn
australia
murdoch
children
research
institut
royal
children
hospit
melbourn
australia
depart
paediatr
univers
melbourn
melbourn
australia
background
purin
nucleosid
phosphorylas
pnp
defici
rare
caus
sever
combin
immunodefici
scid
diagnosi
challeng
may
delay
result
signific
morbid
mortal
affect
patient
report
case
pnp
defici
diagnosi
facilit
urin
metabol
screen
inclus
pnp
substrat
case
report
old
boy
born
parent
asian
descent
diagnos
pnp
defici
scid
month
age
diagnosi
made
follow
investig
gross
motor
development
delay
mean
urin
metabol
screen
demonstr
presenc
increas
substrat
pnp
suggest
enzym
defici
subsequ
investig
demonstr
undetect
red
blood
cell
pnp
enzym
level
genet
test
confirm
compound
heterozyg
mutat
pnp
gene
immunolog
investig
consist
diagnosi
pnp
defici
scid
time
diagnosi
patient
clinic
well
thrive
signific
infect
underw
match
unrel
bone
marrow
haematopoiet
stem
cell
transplant
hsct
month
age
condit
regimen
immunolog
investig
day
demonstr
evid
earli
immun
reconstitut
conclus
diagnosi
rare
form
atyp
scid
difficult
subsequ
delay
treatment
affect
patient
present
case
pnp
defici
scid
diagnosi
initi
suspect
base
result
urin
metabol
screen
follow
propos
urin
metabol
screen
inclus
pnp
substrat
use
earli
identif
children
time
first
present
development
delay
andor
neurolog
symptom
time
diagnosi
children
becom
unwel
infect
facilit
earlier
treatment
potenti
cur
hsct
sarah
sasson
sandi
smith
william
sewel
adrienn
morey
mark
danta
louis
emmett
anthoni
kelleh
keith
fay
tri
phan
immunopatholog
depart
sydpath
st
vincent
hospit
sydney
australia
kirbi
institut
unsw
sydney
australia
garvan
institut
sydney
australia
anatom
patholog
depart
sydpath
st
vincent
hospit
sydney
australia
depart
gastroenterolog
st
vincent
hospit
sydney
australia
depart
nuclear
medicin
st
vincent
hospit
sydney
australia
hiv
immunolog
infecti
diseas
depart
st
vincent
hospit
sydney
australia
depart
haematolog
st
vincent
hospit
sydney
australia
background
common
variabl
immunodefici
disord
cvid
characteris
antibodi
product
failur
classic
present
third
decad
recurr
infect
subset
cvid
patient
suffer
recurr
infect
high
rate
inflammatori
autoimmun
lymphoprolif
disord
lymphoma
second
group
face
diagnost
manag
challeng
higher
mortal
rate
case
report
hospitalis
h
influenza
pneumonia
first
major
infect
examin
found
lymphadenopathi
investig
reveal
panhypogammaglobulinaemia
ct
demonstr
endobronchi
infect
hepatosplenomegali
axilla
ln
biopsi
found
reactiv
hyperplasia
investig
autoimmun
infect
malign
caus
lymphadenopathi
andor
hypogammaglobulinaemia
unremark
patient
treat
intraven
immunoglobulin
ivig
antibiot
steroid
recov
discharg
receiv
monthli
outpati
ivig
year
splenomegali
lymphadenopathi
worsen
pet
scan
show
widespread
metabol
activ
ln
consist
lymphoma
left
axilla
ln
fna
cytolog
suggest
follicular
lymphoma
monoclon
popul
consist
lymphoma
demonstr
subsequ
left
axillari
ln
excis
demonstr
enlarg
atyp
reactiv
follicular
structur
previous
describ
popul
could
found
peripher
blood
immunophenotyp
normal
monoclon
popul
describ
present
manag
problem
treat
physician
discuss
patient
atyp
cvid
present
patholog
address
replac
immunoglobulin
abnorm
monoclon
popul
detect
cytolog
may
secondari
sampl
bia
atyp
ln
hyperplasia
popul
may
transient
andor
uncertain
malign
potenti
conclus
atyp
cvid
may
present
signific
lymphoprolif
diseas
transient
monoclon
popul
indetermin
malign
potenti
patient
high
risk
lymphoma
treatment
chemotherapi
rituximab
monotherapi
weigh
care
monitor
watch
wait
approach
jodi
tansi
michaela
luca
andrew
luca
peter
hollingsworth
sir
charl
gairdner
hospit
perth
australia
harri
perkin
institut
medic
research
perth
australia
describ
case
nurs
histori
sever
atopi
evidenc
high
serum
ige
asthma
frequent
episod
anaphylaxi
requir
adrenalin
trigger
anaphylaxi
includ
trace
amount
fish
latex
protein
intraven
contrast
parenter
iron
influenza
vaccin
also
experienc
episod
idiopath
anaphylaxi
system
mast
cell
disord
exclud
normal
bone
marrow
examin
baselin
mast
cell
tryptas
mct
level
sinc
octob
patient
receiv
omalizumab
mg
fortnightli
dramat
reduct
frequenc
episod
anaphylaxi
mark
improv
asthma
control
interrupt
therapi
consist
result
worsen
asthma
control
howev
experienc
iatrogen
anaphylaxi
everi
dose
omalizumab
reaction
stereotyp
characteris
restless
itch
nausea
vomit
stridor
wheez
appar
minut
post
inject
maxim
minut
episod
anaphylaxi
associ
hypotens
elev
mct
complement
consumpt
desensitis
attempt
abandon
due
critic
worsen
asthma
control
reaction
sever
omalizumab
routin
administ
prophylact
adrenalin
infus
intens
care
unit
pathogenesi
reaction
unknown
evid
ige
posit
skin
prick
test
omalizumab
specif
detect
immunospot
omalizumab
humanis
monoclon
bind
free
receptor
bound
ige
report
rate
anaphylaxi
omalizumab
low
mechan
omalizumab
caus
anaphylaxi
unclear
ige
bound
receptor
mast
cell
activ
complement
postul
role
complex
investig
role
platelet
activ
factor
hui
wen
tee
robert
g
stirl
mark
hew
allergi
asthma
clinic
immunolog
servic
alfr
hospit
melbourn
australia
describ
unusu
case
year
old
femal
present
sever
abdomin
pain
associ
mark
peripher
eosinophilia
peak
eosinophil
count
background
intermitt
abdomin
pain
year
gastroscopi
flexibl
sigmoidoscopi
show
presenc
eosinophil
infiltr
within
antral
duoden
sigmoid
biopsi
apart
elev
peripher
eosinophilia
biochem
marker
includ
celiac
serolog
unremark
stool
microscopi
ova
cyst
parasit
neg
diagnosi
made
allergiceosinophil
oesophagogastroenter
allergi
clinic
immunolog
team
involv
care
advic
test
prior
embark
elimin
diet
patient
describ
symptom
consist
pinworm
infest
given
rise
eosinophil
count
recommend
includ
empir
treatment
parasit
prescrib
albendazol
ivermectin
eosinophilia
rapidli
improv
month
post
hospit
admiss
abdomin
symptom
peripher
eosinophilia
complet
resolv
repeat
gastroscopi
biopsi
stomach
duodenum
show
complet
resolut
previou
eosinophil
infiltr
case
highlight
import
full
consider
broad
differenti
diagnosi
prior
embark
restrict
elimin
diet
consid
therapi
eosinophil
oesophagogastroenter
peripher
eosinophilia
grace
thompson
royal
perth
hospit
perth
australia
immun
dysregul
polyendocrinopathi
enteropathi
x
link
syndrom
ipex
syndrom
rare
life
threaten
disord
caus
mutat
forkhead
box
gene
key
transcript
factor
regulatori
cell
function
ipex
tradit
sever
earli
onset
enter
failur
thrive
eczema
immunodefici
autoimmun
phenomena
particularli
neonat
diabet
without
treatment
ipex
univers
fatal
cur
treatment
haemopoeit
stem
cell
transplant
thought
give
best
outcom
prevent
organ
damag
side
effect
immunosuppress
therapi
signific
divers
clinic
present
outcom
ipex
patient
littl
correl
clinic
phenotyp
express
regulatori
cell
function
assay
genotyp
oldest
survivor
condit
report
literatur
date
yr
describ
case
yr
old
gentleman
ipex
syndrom
patient
suffer
asthma
eczema
week
enteropathi
yr
requir
colectomi
yr
recurr
pneumonia
oral
ocular
herp
simplex
despit
describ
live
full
activ
life
recent
medic
problem
autoimmun
haemolyt
anaemia
massiv
splenomegali
recurr
intestin
varic
haemorrhag
grandson
diagnos
ipex
syndrom
present
neonat
diabet
diagnos
found
mutat
normal
number
regulatori
cell
low
flow
cytometri
case
illustr
heterogen
clinic
manifest
condit
lack
genotyp
phenotyp
correl
increas
awar
ipex
syndrom
milder
phenotyp
prompt
test
wider
group
patient
given
divers
would
valuabl
find
biomark
predict
diseas
sever
help
guid
manag
includ
need
stem
cell
transplant
